1. A spontaneous estrogen dependent, tamoxifen sensitive mouse mammary tumor: a new model system to study hormone-responsiveness in immune competent mice

   • Marina Simian
   • Teresita Manzur
   • Slobodanka Klein

   Preclinical Study 09 January 2008 Pages: 1 - 8

   

2. 2-Methoxyestradiol and multidrug resistance: can 2-methoxyestradiol chemosensitize resistant breast cancer cells?

   • Samar S. Azab
   • Salama A. Salama
   • Ayman Al-Hendy

   Preclinical Study 29 January 2008 Pages: 9 - 19

   

3. Systemic targeting of metastatic human breast tumor xenografts by Coxsackievirus A21

   • Kathryn A. Skelding
   • Richard D. Barry
   • Darren R. Shafren

   Preclinical Study 07 February 2008 Pages: 21 - 30

   

4. 25-Hydroxyvitamin D₃ is a natural chemopreventive agent against carcinogen induced precancerous lesions in mouse mammary gland organ culture

   • Xinjian Peng
   • Michael Hawthorne
   • Rajendra G. Mehta

   Preclinical Study 20 January 2008 Pages: 31 - 41

   

5. Evidence for a role of the Simian Virus 40 in human breast carcinomas

   • M. Hachana
   • M. Trimeche
   • S. Korbi

   Preclinical Study 18 January 2008 Pages: 43 - 58

   

6. Loss of expression of chromosome 16q genes DPEP1 and CTCF in lobular carcinoma in situ of the breast

   • Andrew R. Green
   • Sophie Krivinskas
   • Ian O. Ellis

   Preclinical Study 23 January 2008 Pages: 59 - 66

   

7. Is BRCA1-5083del19, identified in breast cancer patients of Sicilian origin, a Calabrian founder mutation?

   • Antonio Russo
   • Valentina Calò
   • Viviana Bazan

   Preclinical Study 29 January 2008 Pages: 67 - 70

   

8. A novel BRCA1 mutation in a Spanish patient with ovarian cancer

   • Josefa Salgado
   • Carmen Gil
   • Jesús García-Foncillas

   Preclinical Study 17 February 2008 Pages: 71 - 73

   

9. Cyclin D1 expression is associated with poor prognostic features in estrogen receptor positive breast cancer

   • Kirsimari Aaltonen
   • Rose-Marie Amini
   • Carl Blomqvist

   Preclinical Study 01 February 2008 Pages: 75 - 82

   

10. Expression of Bmi-1 protein in tumor tissues is associated with favorable prognosis in breast cancer patients

    • Young Jin Choi
    • Yoon La Choi
    • Seok Jin Nam

    Preclinical Study 29 January 2008 Pages: 83 - 93

    

11. Common adjuvant breast cancer therapies do not inhibit cancer vaccine induced T cell immunity

    • Andrew L. Coveler
    • Vivian Goodell
    • Mary L. Disis

    Preclinical Study 31 January 2008 Pages: 95 - 100

    

12. Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERα negative MDA-MB-435 breast cancer model

    • Kathryn N. Phoenix
    • Frank Vumbaca
    • Kevin P. Claffey

    Preclinical Study 07 February 2008 Pages: 101 - 111

    

13. RUNX3 inactivation by frequent promoter hypermethylation and protein mislocalization constitute an early event in breast cancer progression

    • Manish Mani Subramaniam
    • Jason Yongsheng Chan
    • Thomas Choudary Putti

    Preclinical Study 07 February 2008 Pages: 113 - 121

    

14. Assessment of different criteria for the pathological complete response (pCR) to primary chemotherapy in breast cancer: standardization is needed

    • Hirofumi Mukai
    • Toru Watanabe
    • Noriyuki Katsumata

    Clinical Trial 10 January 2008 Pages: 123 - 128

    

15. Accuracy of frozen section of sentinel lymph nodes: a prospective analysis of 659 breast cancer patients of the Swiss multicenter study

    • Igor Langer
    • Ulrich Guller
    • For the Swiss Multicenter Study Group Sentinel Lymph Node in Breast Cancer

    Clinical Trial 23 February 2008 Pages: 129 - 136

    

16. Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93

    • Beat Thürlimann
    • Karen N. Price
    • Aron Goldhirsch

    Clinical Trial 08 February 2008 Pages: 137 - 144

    

17. Increase in response rate by prolonged treatment with neoadjuvant letrozole

    • J. Michael Dixon
    • Lorna Renshaw
    • William R. Miller

    Clinical Trial 09 February 2008 Pages: 145 - 151

    

18. Joint effects of body size, energy intake, and physical activity on breast cancer risk

    • Aesun Shin
    • Charles E. Matthews
    • Wei Zheng

    Epidemiology 29 January 2008 Pages: 153 - 161

    

19. Effect of a low-fat, high-carbohydrate dietary intervention on change in mammographic density over menopause

    • Lisa J. Martin
    • Carolyn V. Greenberg
    • Norman F. Boyd

    Epidemiology 23 January 2008 Pages: 163 - 172

    

20. Stage migration due to introduction of the sentinel node procedure: a population-based study

    • A. J. G. Maaskant
    • L. V. van de Poll-Franse
    • G. A. P. Nieuwenhuijzen

    Epidemiology 08 February 2008 Pages: 173 - 179

    

21. Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive

    • Ben Van Calster
    • Isabelle Vanden Bempt
    • Patrick Neven

    Epidemiology 09 February 2008 Pages: 181 - 187

22. Human epidermal growth factor receptor-2 and estrogen receptor expression, a demonstration project using the residual tissue respository of the Surveillance, Epidemiology, and End Results (SEER) program

    • W. F. Anderson
    • S. Luo
    • M. E. Sherman

    Epidemiology 07 February 2008 Pages: 189 - 196

    

23. Association of polymorphisms of angiogenesis genes with breast cancer

    • H. Clar
    • P. Krippl
    • U. Langsenlehner

    Letter to the editor 22 January 2008 Pages: 197 - 198